Please see the letter below which was sent to me by Dr. Sin Lee of Milford Molecular Diagnostics who has a $57.1 Million Lyme Disease Lawsuit Filed Against the CDC
Dr. Lee's lawsuit:
For the record: the CDC has implemented a Real-time polymerase chain reaction test kit for the coronavirus (DNA direct detection method). Nearly four decades into the Lyme disease epidemic we are still using antiquated serology because serology cannot be used to gauge treatment failure or success or identify persistent infection keeping the IDSA doctrine intact; “Lyme is hard to catch and easily treated.” Direct detection methods for Lyme disease must be avoided at all costs.
Coronavirus Disease 2019 (COVID-19) Situation Summary
https://www.cdc.gov/coronavirus/2019-ncov/summary.html
--------- Original Message ----------
From: CARL TUTTLE <runagain@comcast.net>
To: tickbornedisease@hhs.gov, jaucott2@jhmi.edu
Cc: (91 undisclosed recipients)
Date: March 1, 2020 at 1:08 PM
Subject: An open letter to CDC attorney Heather Huntley
To the Tick-Borne Disease Working Group:
Please see the correspondence below from Dr. Sin Lee of Milford Molecular Diagnostics.
---------- Original Message ----------
From: Sin Lee <shlee01@snet.net>
To: hhh1@cdc.gov
Cc: CARL TUTTLE <runagain@comcast.net>
Date: March 1, 2020 at 11:14 AM
Subject: An open letter to CDC attorney Heather Huntley
Dear Attorney Huntley:
I am the Plaintiff-Appellant in the United States Court of Appeals FOR THE FEDERAL CIRCUIT case No. 19-2060-JL.
But this letter does not concern the lawsuit. So I did not go through my lawyers involved in this case.
Per your previous advice, I am sending all letters addressed to the CDC through you.
So, please answer the question posed in the attached letter.
Thank you.
Sincerely,
Sin Hang Lee, MD
Carl Tuttle’s response sent to Attorney Huntley:
-------- Original Message ----------
From: CARL TUTTLE <runagain@comcast.net>
To: Sin Lee <shlee01@snet.net>, hhh1@cdc.gov
Date: March 1, 2020 at 11:27 AM
Subject: Re: An open letter to CDC attorney Heather Huntley
Thank you Dr. Lee!
To: Attorney Huntley,
Dr. Lee's letter will be posted to social media for the world to see as what has been deceitfully established by the CDC here in America is wreaking havoc globally. This antibiotic resistant/tolerant superbug has been well hidden from the public through avoidance of direct detection methods.
Direct detection methods have recently identified chronic Lyme disease in France:
PETITION UPDATE
Chronic Lyme disease in France
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/25825323
Sincerely,
Carl Tuttle
Lyme Endemic Hudson, NH
Dr. Lee’s open letter to CDC attorney Heather Huntley: (Attached)
Attorney Heather Huntley
Centers for Disease Control and Prevention
1600 Clifton Road NE M/S D-53
Atlanta, GA 30329
Open Letter via email: hhh1@cdc.gov
March 1, 2020
Re: Lyme Disease and COVID-19 infection
Dear Attorney Huntley:
I am the Plaintiff-Appellant in the United States Court of Appeals FOR THE FEDERAL CIRCUIT case No. 19-2060-JL. This case is against the Centers for Disease Control and Prevention (CDC) about breach of a contract to continue evaluation of polymerase chain reaction (PCR)/DNA sequencing against the two-tier serology test in the diagnosis of Lyme disease infections for better patient care.
You are the CDC lawyer who is blocking a public hearing in court through a series of legal maneuvers.
This letter requests that you on behalf of the CDC answer an extremely relevant question in view of the current COVID-19 outbreak:
Why is the CDC not using a two-tier serology test for the diagnosis of COVID-19 infection, as for Lyme disease infection?
I think both the Lyme disease patients and potential COVID-19 patients would like to know the answers.
Thank you in advance.
Sincerely,
Sin Hang Lee, MD